Pilot Study of the Impact of Giant Cell Arteritis and Its Treatment on the Autonomy of the Elderly in the First Year of Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-17

Study Completion Date

2022-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Giant cell arteritis is the leading cause of vasculitis in the elderly. No work evaluates its impact on autonomy. At the diagnosis a gerontological evaluation will be carried out including the scores ADL, iADL, MNA, SF 36, SPPB, FRIED and GDS. A monthly telephone reassessment will collect ADL and iADL. The end-of-study consultation at M12, conducted by a geriatrician, will have the same scores as at M0. This will make it possible to evaluate the difference in the functional autonomy score between M0 and M12 in the elderly with ACG.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism

NCT03076866

Inflammatory Disease Rheumatoid Arthritis Spondyloarthritis

UNKNOWN

Cardiovascular Risk and Chronic Inflammatory Rheumatism

NCT03187444

Rheumatology Cardiovascular Diseases Arthritis, Rheumatoid +1 more

ACTIVE_NOT_RECRUITING NA

French National Registry: ART REGISTRY (Observational Study)

NCT03062865

RheumatoId Arthritis

UNKNOWN

Cohort Project of Patients With Inflammatory Rheumatism

NCT06059430

Rheumatoid Arthritis Spondyloarthritis, Axial Psoriatic Arthritis

NOT_YET_RECRUITING

Video Coaching of Physical Activity in Axial Spondyloarthritis

NCT03965650

Axial Spondyloarthritis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Giant Cell Arteritis in Dependency of Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

assessment by questionnaire

Assessment by questionnaire

Intervention Type OTHER

At diagnosis a gerontological evaluation will be carried out including the following tests: ADL, iADL, MNA, SF 36, SPPB, FRIED criteria and GDS. The set of scales and scores of the procedure is commonly used in geriatrics to assess the fragility of the patient.

A monthly telephone reassessment conducted by an ARC will collect ADL and iADL from the first month to the eleventh month. The end-of-study consultation will be conducted by a geriatrician at the 12th month and will include the following tests: ADL, iADL, MNA, SF 36, the SPPB, the criteria of FRIED and the GDS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment by questionnaire

At diagnosis a gerontological evaluation will be carried out including the following tests: ADL, iADL, MNA, SF 36, SPPB, FRIED criteria and GDS. The set of scales and scores of the procedure is commonly used in geriatrics to assess the fragility of the patient.

A monthly telephone reassessment conducted by an ARC will collect ADL and iADL from the first month to the eleventh month. The end-of-study consultation will be conducted by a geriatrician at the 12th month and will include the following tests: ADL, iADL, MNA, SF 36, the SPPB, the criteria of FRIED and the GDS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 65 years with at least 2 comorbidities \* present, or age greater than or equal to 75 years
* Diagnosis of ACG meeting the diagnostic criteria of ACG 1990 ACR

* comorbidity = chronic pathology

Exclusion Criteria

* Neoplastic pathology under treatment
* Brain pathology with motor disability
* Dementia at a severe stage (MMS \<22/30)
* Unable to answer the phone
* Participation in a therapeutic clinical trial

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No